oxophenylarsine has been researched along with Uterine Cervical Neoplasms in 1 studies
oxophenylarsine: inhibits protein-tyrosine-phosphatase
phenylarsine oxide : An arsine oxide derived from phenylarsine.
Uterine Cervical Neoplasms: Tumors or cancer of the UTERINE CERVIX.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lee, HL | 1 |
Park, MH | 1 |
Hong, JE | 1 |
Kim, DH | 1 |
Kim, JY | 1 |
Seo, HO | 1 |
Han, SB | 1 |
Yoon, JH | 1 |
Lee, WH | 1 |
Song, HS | 1 |
Lee, JI | 1 |
Lee, US | 1 |
Song, MJ | 1 |
Hong, JT | 1 |
1 other study available for oxophenylarsine and Uterine Cervical Neoplasms
Article | Year |
---|---|
Inhibitory effect of snake venom toxin on NF-κB activity prevents human cervical cancer cell growth via increase of death receptor 3 and 5 expression.
Topics: Animals; Apoptosis; Arsenicals; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; | 2016 |